Open Label Study Assessing Effectiveness Of Amlodipine/At... | NCT00330785 | Trialant

Open Label Study Assessing Effectiveness Of Amlodipine/At... | NCT00330785 | Trialant

Outcomes Module

Secondary Outcomes

Measure	Description	Time Frame
To assess changes from baseline to end of treatment for the following efficacy
parameters: LDL-C, total cholesterol (TC), triglycerides, high-density lipoprotein

Contacts/Locations Module

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
19407658	Derived	Richard Hobbs FD, Gensini G, John Mancini GB, Manolis AJ, Bauer B, Genest J, Feldman RD, Harvey P, Jenssen TG, da Silva PM; JEWEL Study Group. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme. Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):472-80. doi: 10.1097/HJR.0b013e32832b63f5.